Back to Trades
Other4
Seaport Therapeutics, Inc.
SPTX
Total Value
$1.1M
Company Information
- Company Name
- Seaport Therapeutics, Inc.
- Ticker Symbol
- SPTX
- CIK
- 0002042347
Insider Information
- Name
- White Lauren
- Role
- Insider
- Location
- BOSTON, MA
Filing Details
- Filing Date
- May 4, 2026
- Transaction Date
- Apr 30, 2026
- Accession Number
- 0001193125-26-204493
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| May 4, 2026 | Common Stock | 6,702 | — | C | — |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Apr 30, 2026 | Derivative | 63,680 | $18.00 | Grant/Award | $1.1M |
| May 4, 2026 | Derivative | 21,052 | — | C | — |
Footnotes
- (F1)Each share of Series B Preferred Stock (the "Preferred Stock") was convertible into Common Stock of the Issuer on a one-for-3.1407 basis at the option of the holder, and automatically converted upon the closing of the Issuer's initial public offering without payment of further consideration. The Preferred Stock had no expiration date.
- (F2)The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 of the Exchange Act, except to the extent of her pecuniary interest therein, if any. This report shall not be deemed an admission that she is a beneficial owner of such shares for the purpose of Section 16 of the Exchange Act, or for any other purpose.
- (F3)The shares underlying this option shall vest in forty-eight (48) equal monthly installments following April 30, 2026, subject to the Reporting Person's continued service on each such vesting date.